Almuradova D.M., Ravshanova N.B., and Abdurakhimov A.I. “Clinical Outcomes of EGFR-Targeted Therapy With Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis”. International Journal of Medical Sciences And Clinical Research, vol. 6, no. 03, Mar. 2026, pp. 82-86, doi:10.37547/ijmscr/Volume06Issue03-18.